. Author manuscript; available in PMC: 2015 Jan 1.

Published in final edited form as: J Pediatr. 2013 Aug 27;164(1):34–39.e2. doi: 10.1016/j.jpeds.2013.07.027

Table 5. Medical complications at follow-up according to treatment assignment (adjusted analysis).

Variable	Dexamethasone	Placebo	RR (95% CI)	P-value
	No. / total No. (%)
Re-hospitalization^*	44/76(58)	40/68(59)	0.96(0.74,1.26)	0.77
Pulmonary medications	28/76(37)	26/68(38)	0.95(0.65,1.39)	0.84
Oxygen use at follow-up^*	5/74(7)	4/67(6)	1.09(0.29,4.07)	0.79

RR is the relative risk of the outcome in the dexamethasone group as compared with the Placebo group. CI denotes confidence interval.

Not adjusted for center because of convergence issues.